A Novo executive noted that many customers are unaware that the company already makes oral semaglutide for type 2 diabetes ...

.

A new class of drug for type 2 diabetes could save thousands of lives each year, a study has found. Researchers described the once-daily SGLT-2 inhibitor tablets as working “very well” for a wide ...

Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the year in 2025. Ozempic isn’t the only drug that mimics the natural GLP-1 ...

Zydus Lifesciences on Wednesday has received approval from the US health regulator to market a generic diabetes drug in the ...

Diabetes drugs that may soon be prescribed more widely in England could save thousands of lives each year, suggests a new ...

Zydus receives US FDA tentative approval for dapagliflozin tablets, 5 mg and 10 mg: Our Bureau, Mumbai Wednesday, February 4, 2026, 17:05 Hrs [IST] Zydus Lifesciences Limited has ...

Zydus Lifesciences has received USFDA approval to market a generic diabetes drug, Dapagliflozin Tablets, in the US. The drug is indicated for improving glycemic control in adults with type 2 diabetes.

Zydus Lifesciences has received tentative approval from the U.S. Food and Drug Administration (U.S. FDA) for diabetes drug Dapagliflozin Tablets, 5 mg and 10 mg, a generic of AstraZeneca ...

Diabetes drugs that may soon be prescribed more widely in England could save thousands of lives each year, suggests a new study by researchers at UCL and the London School of Hygiene & Tropical ...